[Factors associated with an unfavorable evolution in patients diagnosed with COVID-19 and followed up in primary care in 2020]. [PDF]
Aten Primaria, 2022 Fernández Pérez MJ +7 more
europepmc +1 more source
[Impact of P-CABs in the Treatment of Acid-related Diseases: an Evidence Review]. [PDF]
Acta Gastroenterol LatinoamRemes-Troche JM +2 more
europepmc +1 more source
[Therapeutic Developments in Eosinophilic Esophagitis]. [PDF]
Acta Gastroenterol Latinoam, 2022 Molina-Infante J, Lucendo AJ.
europepmc +1 more source
[Clinical determinants of levothyroxine dosage adjusted for various body weights]. [PDF]
Rev Med Inst Mex Seguro SocGarcía-Cabello R +1 more
europepmc +1 more source
[Deprescription in old people: It's time to take action]. [PDF]
Aten Primaria, 2022 García Pliego RA +3 more
europepmc +1 more source
[[Non-Inferiority Clinical Trials]]. [PDF]
Acta Gastroenterol Latinoam, 2022 Pizarro R.
europepmc +1 more source
[Use of Los Angeles Classification in Erosive Esophagitis: analysis of inter-observer and intra-observer agreement]. [PDF]
Acta Gastroenterol Latinoamde Los Rios AA +5 more
europepmc +1 more source
Correcto uso de fármacos inhibidores de la bomba de protones frente a fármacos antiácidos
Farmacéuticos Comunitarios, 2022 openaire +1 more source
Evidencia insuficiente para indicar inhibidores de la bomba de protones en el tratamiento del asma
Evidencia. Actualización en la Práctica Ambulatoria, 2011 Agustín Segalini, Sergio Terrasa
doaj +1 more source